713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trial
Oliver Klein, Matteo S. Carlino, M. Michael, Craig Underhill, Jimmy Bok Yan So, Damien Kee, Yoland Antill, W-S. Lam, Henry Chan, Rosemary Harrup, Anthony J Hamilton, Jamie Palmer, Dawn Thomas, Ken Wilkie, Jonathan Cebon, Bo Gao
Topics & Concepts
MedicineNivolumabIpilimumabOncologyInternal medicineImmunotherapyCancerOvarian cancer diagnosis and treatmentRenal and related cancersBladder and Urothelial Cancer Treatments